Blockchain

FoundationLogic Unveils Silent Home Miner at Mining Disrupt 2024

Singapore, Singapore, July 4th, 2024, Chainwire

The industry-leading brand of DOGE and Litecoin mining machines announced a new product line at the recent Mining Disrupt 2024 conference.

FoundationLogic, the fabless semiconductor design company behind high-performance ElphaPex Dogecoin (DOGE) + Litecoin (LTC) miners, took center stage at Mining Disrupt 2024 in Miami, Florida, held from 24-26 June. 

At the event, FoundationLogic unveiled its new product line for silent home miners.

Like the pro ElphaPex DG 1/DG 1+ models, the new device, dubbed ElphaPex DG Home 1, is powered by the Proof-of-Work (PoW) Scrypt algorithm, offering dual DOGE and LTC rewards. 

Designed for a new era of home mining, ElphaPex DG Home 1 promises silent, low-maintenance, yet performant DOGE + LTC mining ensured by water-cooling technology. 

Set to be released in Q4, 2024, the new model boasts a hashrate of 2000M, power of 620W and power efficiency of 0.31JM. Upon launch, ElphaPex DG Home 1 will be available for immediate purchase through the ElphaPex official website. 

ElphaPex DG Home 1 drew an immediate reaction from crypto mining insiders, with some of the industry’s major influencers sharing photos on social media as soon as the model was showcased. Specifically, they described the new water-cooled miner as “silent, powerful, and efficient”. 

“This new silent home miner embodies our commitment at ElphaPex to be everyone’s miner partner, regardless of the scale of operations” said Ben Weng, VP of Product at FoundationLogic. “We were pleased by the enthusiastic response we saw at the conference, as many visitors wanted to get one on the spot. Luckily, it won’t be long before everyone can start dual mining DOGE and Litecoin from the comfort of their homes”.

“ElphaPex products have achieved a remarkable milestone in the DOGE & Litecoin mining chip industry and we’re excited to launch this new product into mass production” said Charles Song, Executive VP at Samsung Foundry. “I believe this is just the beginning of a very bright future for ElphaPex”.

In addition to launching its newest product, FoundationLogic made a strong impression at the event, drawing attention from industry insiders and influential figures.

As the main sponsor of Mining Disrupt 2024, the Scrypt mining hardware company hosted the official opening party and operated one of the event’s busiest booths, featuring engaging activities and giveaways.

Another standout at the conference was FoundationLogic’s keynote presentation.

During the keynote, the company’s representatives emphasized their commitment to advancing Scrypt mining, highlighting its growing potential for miners. This is particularly significant in light of bitcoin’s recent halving, which has posed challenges across the industry due to reduced rewards. They also pointed out several key advantages of Scrypt hardware over SHA-256 hardware, including better cash flow, ROI, and equipment lifecycle.

Another highlight of the presentation was the success of the ElphaPex DG 1+, an ASIC miner launched earlier this year at Blockchain Life 2024 in Dubai. As FoundationLogic’s flagship model, it has set a new standard in the market and continues to dominate the Scrypt mining sector with a hashrate of 14000M, power of 3920W and efficiency of 0.28JM.

Considering recent price trends and the increasing availability of reliable Scrypt mining hardware provided by FoundationLogic, leveraging DOGE’s meme advantage alongside LTC’s solid track record may offer a strategy for mining operations this year.

About FoundationLogic

FoundationLogic is a Singapore-based fabless semiconductor design company dedicated to revolutionizing the cryptocurrency mining industry. With a focus on innovation and reliability, FoundationLogic utilizes state-of-the-art ASIC chips designed in-house and subjects its products to rigorous field testing. Through its flagship ElphaPex series, FoundationLogic empowers mining enthusiasts and professionals with cutting-edge, accessible machines, setting new standards for efficiency and performance in the field. For more information, users can visit elphapex.com

X: https://x.com/ElphaPex

LinkedIn: https://www.linkedin.com/company/100958166

Contact

VP of Product
Ben Weng
[email protected]

PostAd_coinrule_banner728x90

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Equasens: 2024 half-year results

2024-09-27T16:00:00Z

Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET)

PRESS RELEASE

2024 half-year results

  • Group results impacted by weaker economic conditions and continuing investment efforts in H1:
    • Revenue: €108.0m, -4.1%
    • Current Operating Income: €20.9m, -24.1%
  • Net Profit attributable to the Group: €17.2m, -21.8%
  • Though with a profit margin that continues to be very positive:
    • Ratio of Current Operating Income (COI) to Sales: 19.3% on a reported basis and 20.0% like-for-like
H1 RESULTS (€M)2023
reported basis
2024
reported basis
Change / Reported basisExternal growthChange / Like-for-like basis
Revenue112.6108.0-4.6-4.1%-3.7-8.3-7.4%
Current operating income (COI)27.520.9-6.6-24.1%0.0-6.7-24.3%
Net Profit22.918.1-4.8-21.0%0.0-4.8-21.1%
Net Profit attributable to the Group22.017.2-4.8-21.8%   

The financial statements for the six-month period ended 30 June 2024 were reviewed and adopted by EQUASENS' Board of Directors, chaired by Thierry Chapusot, on 27 September 2024. These interim consolidated financial statements were subject to a limited review by the Statutory Auditors.

_____

Results at 30 June 2024

H1 Current Operating Income / Division2023
reported basis
2024
reported basis
Change / Reported basisExternal growthChange / Like-for-like basis
Pharmagest18.414.1-4.3-23.5%-0.1-4.4-24.0%
Axigate Link4.64.4-0.2-4.9% -0.2-4.9%
e-Connect3.62.5-1.1-29.9% -1.1-29.9%
Medical Solutions1.30.0-1.3-100.0%0.1-1.2-92.5%
Fintech-0.4-0.10.369.3% 0.3-69.3%
Current Operating Income27.520.9-6.6-24.1%0.0-6.7-24.3%
  • PHARMAGEST division: a contraction in earnings reflecting lower sales and reinforced teams in Europe (COI/Sales: 17.2%)

The decline in the Division's operating income is mainly attributable to a reduction in sales in France in the configuration and hardware segment. In a persistently challenging economic environment, the Division continued to focus its commercial strategy on acquiring new customers and regularly rolling out new software and hardware solutions.
Despite this, recurring revenues were bolstered by the combined contribution of new SaaS offerings and contract indexation.
To accelerate the deployment of solutions in Europe, the R&D and sales teams continued to be strengthened.

  • AXIGATE LINK division: the profit margin remains high (COI/Sales: 28.6%)

Strategic investments to support the roll-out of SaaS solutions such as TitanLink for Nursing Homes in Europe, and the extension of homecare services, have temporarily weighed on the Division's results.

  • E-CONNECT division: current operating income declined in response to lower sales (COI/Sales: 45.4%)

As previously reported, H1 2023 sales and earnings were boosted by the announced discontinuation of sales of Application Reader Terminals.
The downturn in business in the first half of 2024 thus reflected the corresponding decline in sales.
Despite this unfavourable environment, the Division demonstrated its ability to adapt by maintaining a healthy profit margin based on tight cost controls.

  • MEDICAL SOLUTIONS division: a year of transition between the Ségur digital healthcare investment programme and a new software solution (COI/Sales: -)

Preparations for the Division's future involving the development of a new software platform and optimising the sales organisation led to significant investments which, in conjunction with lower sales following the end of the Ségur programme roll-out, weighed on the Division's results. Recurring revenues rose 13.7%, resulting in a gross margin of 72.8%.

  • FINTECH division: efforts to stabilise the business paid off in H1, with an improvement in earnings of €0.3m (COI/Sales: -)

Consolidated balance sheet highlights

  • Cash flow after interest and tax maintained a positive trend at €20.8m.
  • Financial investments, through acquisitions as well as capital expenditures, in particular for the EQUASENS private healthcare cloud, continued, with more than €16.0m committed in H1.
  • The net financial surplus at 30/06/2024 of €87.9m takes into account a change in presentation of IFRS 16 lease liabilities and put options for minority shareholders of €10.8m (recognised under other liabilities versus financial liabilities previously).

2024 outlook

  • The Group maintains its forecast for a return to revenue growth starting in the second half of 2024, and an acceleration in 2025 driven by current investments and an economic climate that looks set to improve, particularly for pharmacies in France.
  • The Group will continue to invest in R&D, infrastructure and sales forces in France and Europe in the second half of 2024. And while this will have a temporary impact on profitability in 2024, it should generate a return on investment from 2025 onwards.
  • With a strategy focused on patients and interoperability, the Group is ideally positioned to seize opportunities for external growth in France and Europe.

Financial calendar:

  • 1 October 2024: Presentation of H1 2024 results
  • 7 November 2024: Publication of Q3 2024 revenue
  • 6 February 2025: Publication of f Q4/FY 2024 revenue

About Group Equasens

With more than 1,300 employees, Equasens Group is today a key player in the European healthcare sector, providing software and hardware solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, hospital-at-home programmes, retirement homes, health centres) in both primary and secondary care sectors.

With operations in in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment B

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable
Included in the Euronext Tech Leaders segment and the European Rising Tech label

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR 0012882389 – Ticker Code: EQS

Get all the news about Equasens Group www.equasens.com and on LinkedIn

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Frédérique Schmidt
Tel: +33 (0)3 83 15 90 67 - [email protected]

Financial communication agency:
FIN’EXTENSO - Isabelle Aprile

Tel.: +33 (0)6 17 38 61 78 - [email protected]

Attachment


GlobeNewsWire News

Recent Comments